Altana Inc, a wholly owned subsidiary of Altana Pharma AG, has acquired the prescription dermatology business from GlaxoSmithKline Consumer Healthcare, a division of GlaxoSmithKline Corporation.

PharmaDerm, a division of Altana Inc, will manufacture and market the former GSK products. These products include Aclovate (alclometasone dipropionate), a synthetic corticosteroid; Cutivate (fluticasone propionate), an anti-inflammatory; Emgel (erythromycin), an antibiotic; Oxistat (oxiconazole nitrate), an anti-fungal; Temovate (clobetasol propionate), an anti-inflammatory, informs a company release.

PharmaDerm, headquartered in Atlanta, GA is a division of Altana Inc, the leading US specialty pharmaceutical manufacturer of topical dermatological prescription products.